Literature DB >> 9495528

Apoptosis and host restriction of vaccinia virus in RK13 cells.

C S Chung1, I A Vasilevskaya, S C Wang, C H Bair, W Chang.   

Abstract

Poxviruses express a number of host range (hr) genes that control virus growth in distinctive cell types. Inactivation of hr gene expression in several reported cases has led to apoptosis of virus-infected cells. In RK13 cells, the K1L gene serves as a hr gene for vaccinia virus. We therefore investigated the effect of K1L expression in apoptosis of RK13 cells. In contrast to other hr genes, no significant increase of apoptosis was detected in RK13 cells infected with a K1L- mutant virus. Also, expression of a CHO hr gene CP77 rescues K1L- mutant virus in RK13 cells with little effect on apoptosis. We then set out an experimental approach to investigate the relationship between apoptosis and host restriction in CHO and RK13 cells. A recombinant vaccinia virus expressing a human bcl-2 gene, bcl2-VV, was constructed. Expression of bcl-2 suppressed apoptosis of virus-infected CHO cells as expected. However, bcl-2 expression did not allow virus growth in CHO cells, suggesting apoptosis suppression is not sufficient to rescue host restriction. Moreover, infection of bcl-2VV in RK13 cells induced significant apoptosis with no reduction on virus production, indicating that apoptosis does not contribute to host restriction. In consideration of this data, we conclude that host restriction of vaccinia virus in CHO and RK13 cells is mediated by a pathway distinct from apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9495528     DOI: 10.1016/s0168-1702(97)00111-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells.

Authors:  Jye-Chian Hsiao; Chien-Chiang Chao; Ming-Jer Young; Yu-Tai Chang; Er-Chieh Cho; Wen Chang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons.

Authors:  Xiangzhi Meng; Canhua Jiang; Janilyn Arsenio; Kevin Dick; Jingxin Cao; Yan Xiang
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

4.  Regulated overexpression of the survival factor bcl-2 in CHO cells increases viable cell density in batch culture and decreases DNA release in extended fixed-bed cultivation.

Authors:  M Fussenegger; D Fassnacht; R Schwartz; J A Zanghi; M Graf; J E Bailey; R Pörtner
Journal:  Cytotechnology       Date:  2000-01       Impact factor: 2.058

Review 5.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

6.  E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.

Authors:  Asisa Volz; Sylvia Jany; Astrid Freudenstein; Markus Lantermann; Holger Ludwig; Gerd Sutter
Journal:  Viruses       Date:  2018-01-04       Impact factor: 5.048

7.  Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTan.

Authors:  Zheng Liu; Shuhui Wang; Qicheng Zhang; Meijuan Tian; Jue Hou; Rongmin Wang; Chang Liu; Xu Ji; Ying Liu; Yiming Shao
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

8.  The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes.

Authors:  Weijun Zhu; Qing Fang; Ke Zhuang; Haibo Wang; Wenbo Yu; Jingying Zhou; Li Liu; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  J Virol Methods       Date:  2007-04-24       Impact factor: 2.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.